Join the battle for biomedical research

1 March 2012 0

Once every seven years an opportunity arises to influence the shape of the European science research effort. This editorial takes a look at what is at stake in the current discussions around the European Research [more]

Once every seven years an opportunity arises to influence the shape of the European science research effort. This editorial takes a look at what is at stake in the current discussions around the European Research Framework...... [ more ]

John Crown: Move aside bureaucrats and let us take a lead

1 March 2012 0

Decisions on how best to deliver high-quality care should be left to the clinicians who run the services. John Crown, who has long played a leading role in both the clinic and research is one [more]

Decisions on how best to deliver high-quality care should be left to the clinicians who run the services. John Crown, who has long played a leading role in both the clinic and research is one of the few oncologists to seek...... [ more ]

International guidelines offer hope of speeding up progress in advanced breast cancer

1 March 2012 0

Patient advocates and professionals alike believe these groundbreaking guidelines will raise standards of care, give much-needed structure to clinical research and improve awareness about a group of patients whose needs have been neglected for too [more]

Patient advocates and professionals alike believe these groundbreaking guidelines will raise standards of care, give much-needed structure to clinical research and improve awareness about a group of patients whose needs...... [ more ]

Endotherapy for Barrett’s oesophagus with early neoplasia

1 March 2012 0

Massimo Conio looks at the evidence for two alternatives to oesophagectomies–endoscopic mucosal resection and radiofrequency ablation–and discusses which patients should be eligible and where the treatments should be carried out. We can safely and effectively [more]

Massimo Conio looks at the evidence for two alternatives to oesophagectomies--endoscopic mucosal resection and radiofrequency ablation--and discusses which patients should be eligible and where the treatments should be carried out... [ more ]

Living with the timebomb of a childhood cancer

1 March 2012 0

Being alert to early signs of cancer gives the best chance of survival. Silja Paavle, reporter on the Estonian daily Öhtuleht, helped to pass on this message with this article which won her a Best [more]

Being alert to early signs of cancer gives the best chance of survival. Silja Paavle, reporter on the Estonian daily Öhtuleht, helped to pass on this message with this article which won her a Best Cancer Reporter merit award.... [ more ]

A world-class centre arises from the French ground-zero

1 March 2012 0

From a disastrous chemical explosion in Toulouse arises an innovative hospital with unique links to research and industry. Jean-Pierre Armand has seen his dream cancer centre at the Toulouse ‘oncopole’ through to completion. “If only [more]

From a disastrous chemical explosion in Toulouse arises an innovative hospital with unique links to research and industry. Jean-Pierre Armand has seen his dream cancer centre at the Toulouse 'oncopole' through to completion. ... [ more ]

How are we doing?

1 March 2012 0

Information on how the performance of individual clinicians, teams and hospitals compares with the best is key to driving up standards in cancer care. ECCO is designing and implementing an audit framework named EURECCA to [more]

Information on how the performance of individual clinicians, teams and hospitals compares with the best is key to driving up standards in cancer care. ECCO is designing and implementing an audit framework named EURECCA to do so. ... [ more ]

The importance of local control in pancreatic cancer

1 March 2012 0

THE ECOG E4201 study adds another piece of information to a growing body of evidence pointing strongly to the importance of local control and the role of radiotherapy in unresectable pancreatic cancer. Based on this [more]

THE ECOG E4201 study adds another piece of information to a growing body of evidence pointing strongly to the importance of local control and the role of radiotherapy in unresectable pancreatic cancer. ... [ more ]

Time for another rethink on prostate cancer screening

1 March 2012 0

Screening for prostate cancer using PSA is a careful balance of benefits and harms. But current US practice involves testing older men who have little to gain and aggressively treating low-risk cancers. Debates about whether [more]

Screening for prostate cancer using PSA is a careful balance of benefits and harms. But current US practice involves testing older men who have little to gain and aggressively treating low-risk cancers. ... [ more ]

Newsround

1 March 2012 0

Everolimus plus octreotide improves progression-free survival in advanced NET => The Lancet The addition of everolimus to octreotide improved progression-free survival in patients with advanced neuroendocrine tumours (NETs) associated with carcinoid syndrome, the phase III [more]

... [ more ]
UA-77507851-1